Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Important European launch reported for Hepsera

May 20, 2003

Stressgen presents preclinical data on CoVal fusion peptide targeting HBV

May 19, 2003

TheraCLEC study for malabsorption completed

May 16, 2003

IND filed for phase II trials of SPI-0211 in postoperative ileus

May 15, 2003

Preliminary results from phase IIb trial of renzapride in c-IBS

May 14, 2003

Cheil Jedang claims two series of COX-2 inhibitors for use in gastrointestinal disorders

May 14, 2003

Vanilloid receptor antagonism prevents DSS-induced colitis in rats

May 14, 2003

Novartis acquires 51% of Idenix capital stock

May 13, 2003

Hepavir B enters the clinic

May 6, 2003

Pilot study for PTI-901 in IBS completes enrollment

May 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026